Percutaneous Gadolinium Injection under MR Guidance to Mark Target for CT-guided Radiofrequency Ablation
Section snippets
CASE REPORT
A 71-year-old woman with a history of lymph-node–positive sigmoid colon cancer resected in 1998 presented to our hospital asymptomatic, but with an increasing carcinoembryonic antigen level. Because of the patient's history of anaphylactic reaction to iodinated contrast material, she underwent noncontrast CT, which revealed no evidence of disease. The patient had both gadolinium-enhanced MR imaging and positron emission tomographic scans which confirmed a solitary 3.0-cm-diameter lesion in the
DISCUSSION
Interventionalists have a number of imaging modalities available to perform image-guided procedures. A number of factors influence which of these modalities will be most appropriate for the given procedure. In the current case, the patient's lesion was not visible with US or noncontrast CT. Her allergic reaction to iodinated contrast material precluded an enhanced CT scan. However, her lesion was very conspicuous on all MR sequences.
MR-compatible biopsy tools are available to perform biopsy
References (8)
- et al.
MR monitoring of tumour thermal therapy
MAGMA
(2001) - et al.
Gadolinium as a CT contrast agent: assessment in a porcine model
Radiology
(1999) - et al.
Gd-DTPA: an alternative contrast medium for CT
J Comput Assist Tomogr
(1994) - et al.
Gadopentetate dimeglumine as an alternative contrast material for use in angiography
AJR Am J Roentgenol
(1993)